rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PGNY
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run?
      Nov 17Yahoo FinancePGNY
      Progyny stock hits 52-week high at 37.16 USD
      Nov 16Investing.comPGNY
      Progyny (PGNY) Is Up 3.85% in One Week: What You Should Know
      Nov 16Yahoo FinancePGNY
      Pregnancy Worker Rule Rollback Puts IVF Time Off At Risk
      Nov 13ForbesPGNY
      Progyny CEO Peter Anevski sells $8.48 million in company stock
      Nov 13Investing.comPGNY
      Executive chairman David Schlanger sells Progyny shares worth $1.25M
      Nov 13Investing.comPGNY
      What Does Progyny's Falling Multiple Really Say?
      Nov 12Yahoo FinancePGNY
      Progyny: 3 Key Takeaways for Long-Term Investors
      Nov 11Yahoo FinancePGNY
      Progyny (PGNY) Stock Gets Fair Value Bump After Strong Results And Raised Guidance

      The recent update to Progyny’s analyst model reflects a higher Fair Value Estimate of US$36.17 compared with US$34.42, which informs how some investors may think about the stock’s price potential. That adjustment sits alongside Street research that mixes optimism around record Q3 2026 results and raised guidance with caution about utilization trends and visibility into 2026. As you read on, you will see how these shifting targets and narratives fit together and how to track Progyny’s evolving...

      Nov 10Yahoo FinancePGNY
      Progyny CEO Peter Anevski sells $6.18 million in company stock
      Nov 10Investing.comPGNY
      Progyny executive chairman David Schlanger sells $5.88M in stock
      Nov 10Investing.comPGNY
      Fertility Treatment Leader Progyny Breaks Out Past Buy Point As Earnings Surge 113%

      Progyny stock broke out past its latest buy point after the company's Q3 earnings surged 113% vs. year-ago period.

      Nov 9Investor's Business DailyPGNY
      Progyny CFO Mark Livingston sells $64,170 in company stock
      Nov 6Investing.comPGNY
      Progyny, Inc. Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinancePGNY
      Wells Fargo raises Progyny stock price target on strong sales growth
      Nov 5Investing.comPGNY
      Citizens raises Progyny stock price target on guidance increase
      Nov 5Investing.comPGNY
      Progyny Q3 Earnings Call Highlights
      Nov 5Yahoo FinancePGNY
      Progyny Inc (PGNY) (Q3 2026) Earnings Call Highlights: Record Selling Season Adds 1. ...
      Nov 5Yahoo FinancePGNY
      Progyny earnings beat, revenue topped estimates
      Nov 5Investing.comPGNY
      Progyny Q3 2026 Earnings Call Transcript
      Nov 4BenzingaPGNY
      Progyny (NASDAQ:PGNY) reports Q3 2026 in line with expectations
      Nov 4Yahoo FinancePGNY
      Progyny (PGNY) Tops Q3 Earnings and Revenue Estimates
      Nov 4Yahoo FinancePGNY
      Progyny: Q3 Earnings Snapshot
      Nov 4Yahoo FinancePGNY
      Progyny, Inc. Announces Third Quarter 2026 Results
      Nov 4Yahoo FinancePGNY
      Progyny (PGNY) Q3 2026 Earnings Call Transcript
      Nov 4The Globe and MailPGNY
      Earnings To Watch: Progyny Inc (PGNY) Q3 2026 -- GF Value Sees 14% Upside
      Nov 3Yahoo FinancePGNY
      Progyny (PGNY) Cuts Guidance And Puts Its Valuation Back In Focus
      Nov 1Yahoo FinancePGNY
      Progyny (PGNY) Stock Looks About Right On Its 56% Run

      Progyny has delivered a sharp 56.1% share price gain over the past year, and that kind of run naturally raises a simple question for holders and onlookers alike. Is the current valuation still grounded in what the business is earning, or has the price moved ahead of its fundamentals? The 56.1% return over the last 12 months puts Progyny in a very different place from three and five years ago. This makes the current earnings based valuation question far more important for anyone considering...

      Nov 1Yahoo FinancePGNY
      Is Lower Revenue Guidance Altering The Investment Case For Progyny Stock (PGNY)?
      Nov 1Yahoo FinancePGNY
      Progyny’s (PGNY) Full-Year Guidance Lowered on Utilization Headwinds
      Oct 30Yahoo FinancePGNY
      New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
      Oct 28Yahoo FinancePGNY
      New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

      More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider careNEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced findings from a new clinical outcomes study showing significant improvements in menopause symptoms among members receiving care through its Menopause and Midlife program

      Oct 26Yahoo FinancePGNY
      What Does Progyny's Falling Multiple Really Say?
      Oct 22Yahoo FinancePGNY
      Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
      Oct 21Yahoo FinancePGNY
      Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
      Oct 19Yahoo FinanceAZTAMRNAPGNYAGL
      Progyny COO Melissa Cummings sells $52,612 in shares
      Oct 17Investing.comPGNY
      Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
      Oct 15Yahoo FinancePGNY
      Analysts’ Opinions Are Mixed on These Healthcare Stocks: Progyny (PGNY) and Merck & Company (MRK)

      Detailed price information for Progyny Inc (PGNY-Q) from The Globe and Mail including charting and trades.

      Oct 9The Globe and MailPGNY
      Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?

      Progyny (PGNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

      Oct 8Yahoo FinancePGNY
      Why Are Progyny (PGNY) Shares Soaring Today
      Oct 7Yahoo FinancePGNY
      Progyny Sees Record Employer Signups, Adding 1.2 Million to Coverage
      Oct 7Yahoo FinancePGNY
      Progyny expects 1.2 million new covered lives in 2027
      Oct 7Investing.comPGNY
      Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
      Oct 7Yahoo FinancePGNY
      Progyny director Kevin Gordon sells $311,858 in shares
      Sep 18Investing.comPGNY
      Progyny (PGNY) Stock Looks Fairly Valued Despite Its 57% Five Year Slide

      Progyny has delivered a mixed ride for shareholders, with the stock climbing over the past year but still showing a steep decline over five years. This puts a sharper spotlight on what investors are really paying for its earnings today. With that backdrop, the key issue is whether the current share price around US$27 fairly reflects the company’s profit engine. Over the past 5 years, Progyny’s share price has fallen 57.5%, which raises the question of whether the market is reassessing how...

      Sep 18Yahoo FinancePGNY
      Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027 (NASDAQ:PGNY)
      Sep 17Seeking AlphaPGNY
      Options Movement At Progyny: KEVIN GORDON Exercises Worth $325K
      Sep 15BenzingaPGNY
      Progyny director Kevin Gordon sells $321,358 in company stock
      Sep 14Investing.comPGNY
      Progyny Insider Sold Shares Worth $321,358, According to a Recent SEC Filing

      Kevin K Gordon, Director, on September 10, 2026, sold 11,500 shares in Progyny (PGNY) for $321,358.

      Sep 14Yahoo FinancePGNY
      Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2

      Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.

      Sep 10Yahoo FinancePGNY

      This is the newest page. Registered accounts read further back.